CRISPR Therapeutics Options Trading: A Deep Dive into Market Sentiment - CRISPR Therapeutics (NASDAQ:CRSP)

Core Insights - Financial giants are showing a bearish sentiment towards CRISPR Therapeutics, with 44% of traders exhibiting bearish tendencies compared to 33% who are bullish [1] - The analysis of options history indicates a significant interest in a price range of $35.0 to $70.0 for CRISPR Therapeutics over the past quarter [2][3] Options Trading Overview - A total of 9 unusual trades were identified, with 4 puts valued at $169,270 and 5 calls valued at $277,530 [1] - The largest options trades observed include a bearish call trade with a strike price of $70.00 and a total trade price of $136.5K, alongside several neutral and bearish put trades [9] Company Performance and Analyst Insights - CRISPR Therapeutics is focused on gene editing using Crispr/Cas9 technology, with its first approved drug targeting sickle-cell disease and transfusion-dependent beta-thalassemia [10][11] - Recent analyst insights suggest an average target price of $87.0, with one analyst maintaining a Buy rating at a target price of $93 and another adjusting their target to $81 [12][13] Current Market Position - The trading volume for CRISPR Therapeutics stands at 772,300, with the stock price at $56.26, reflecting a decrease of -0.27% [15]